3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
Mucositis
1
Hematologic Neoplasms
1
HIV Infections
1
Gallbladder Neoplasms
1
Breast Carcinoma In Situ
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiotherapy
2
Glutamine
2
Fibroblast Growth Factor 7
2
oxycodone-acetaminophen
1
cyclohexaneacetic acid
1
acetaminophen, hydrocodone drug combination
1
Surveys and Questionnaires
1
Sucralfate
1
Standard of Care
1
Passive Cutaneous Anaphylaxis
1
Pain Management
1
Neck Dissection
1
Morphine
1
Methods
1
Methadone
1
Laser Therapy
1
Ketamine
1
Ibuprofen
1
Hydromorphone
1
Gabapentin
1
Fentanyl
1
Educational Status
1
Early Intervention, Educational
1
Doxepin
1
Cisplatin
1
Benzydamine
1
Analgesia
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Mucositis
×
Laser Therapy
×
Clear all
NCT02696408
2020-01-29
STOP MUCITES
Institut de Cancérologie de la Loire
Phase 3
Completed
234 enrolled